Friday, the U.S. Court in the Northern District of Texas issued a stay of the FDA’s approval of the chemical abortion drug mifepristone, meaning the drug would not be available for elective abortions throughout the nation. However, the stay is delayed for seven days, giving the Biden/Harris Administration time to appeal the ruling to the Fifth Circuit Court of Appeals.In the